Related references
Note: Only part of the references are listed.NK cell-based immunotherapy for malignant diseases
Min Cheng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2013)
CDK8-Mediated STAT1-S727 Phosphorylation Restrains NK Cell Cytotoxicity and Tumor Surveillance
Eva Maria Putz et al.
CELL REPORTS (2013)
CDK8 Maintains Tumor Dedifferentiation and Embryonic Stem Cell Pluripotency
Adam S. Adler et al.
CANCER RESEARCH (2012)
Natural Killer Cells Preferentially Target Cancer Stem Cells; Role of Monocytes in Protection Against NK Cell Mediated Lysis of Cancer Stem Cells
Anahid Jewett et al.
CURRENT DRUG DELIVERY (2012)
The histone variant macroH2A suppresses melanoma progression through regulation of CDK8
Avnish Kapoor et al.
NATURE (2010)
CDK8 is a colorectal cancer oncogene that regulates β-catenin activity
Ron Firestein et al.
NATURE (2008)
STAT1 acts as a tumor promoter for leukemia development
Boris Kovacic et al.
CANCER CELL (2006)
Share Paper
